Prostate Cancer and Hair Loss in Men

Male pattern hair loss is not just an aesthetic problem. hair mesotherapy to prevent hair loss, prp, and to regain their hairy appearance, they should know that male pattern baldness is a risk factor for other serious diseases such as cardiovascular diseases, scalp cancer, and prostate cancer. Hair transplantation with the Fue method is only useful for solving cosmetic problems. Hair loss and hair health are part of general health. If he calls in health platforms where modern medical methods are used, his doctor will inform him about these issues.

Male pattern hair loss and prostate cancer: A 2011 study investigated the relationship between hair loss and prostate cancer in men;

Androgen hormones play a role in both male pattern baldness (androgenic alopecia) and prostate cancer. In this study conducted on 699 people, it was investigated whether early-onset male pattern baldness is associated with the development of prostate cancer in the future. As a result, it has been shown that the rate of patients with prostate cancer to develop male pattern baldness at the age of 20 is twice the normal rate. No correlation was found between early onset baldness and early diagnosis of prostate cancer. This study shows an association between early-onset male pattern baldness and developing prostate cancer. Whether patients with early-onset male pattern baldness should have routine prostate cancer screening or whether they should use 5-alpha reductase inhibitors as a preventative may be the subject of future research. Therefore, while the baldness problems of people with male pattern baldness are being treated with hair transfer, patients should be warned about the risks related to general health.

Does it cause Grade Prostate Cancer?

The subject of whether it causes grade 1 prostate cancer was investigated in a scientific article published in the journal Dermatol Ther in 2010. Finasteride, which is used at a dose of 1 mg per day, is a method that has been used for the prevention of male pattern baldness in men. Although finasteride has been used successfully for this purpose, the claims that it increases the risk of developing higher-grade prostate cancer in a scientific article published by the “Prostate Cancer Prevention Initiative” (PCPT) are confusing.

In conclusion, the use of a treatment monitoring guideline based on extensive research is recommended for patients using finasteride, which provides reliable treatment of male pattern baldness without the worry of developing high-grade prostate cancer. FUE treatment of male pattern baldness does not have any systematic side effects.

Prostate Cancer and Hair Loss in Men

Relationship between prostate cancer and baldness; Hair loss is quite common in young men and half of these men find themselves less attractive. 75 percent of young men with hair loss have self-confidence problems. If there is more than normal DHT hormone in the bloodstream, hair follicles shrink, hair strands become thinner and start to grow more slowly.

High testosterone levels increase the risk of hair loss if there is a family history of baldness.

Drugs that reduce testosterone levels are used in patients with prostate cancer. Because if the cancer has developed, in some types of prostate cancer, testosterone can accelerate the growth of these tumors. Since both prostate cancer and male pattern baldness are considered androgenic conditions, there are various studies on the relationship between the two.

But the results contradict each other.

For example, a study investigating the relationship between prostate cancer and hair loss was conducted on 2000 people aged between 40 (forty) and 47 (forty-seven). Half of these 2000 people had prostate cancer. In this study, a comparison was made between the patients whose hair was thinned and shed before the age of 30 (thirty) and those who did not lose their hair before the age of 30 (thirty) in terms of the rate of prostate cancer development. Patients whose hair lines regressed before the age of 30 (thirty) and who had an opening in the vertex region were found to be the lowest risk group in terms of the risk of developing prostate cancer. This study alone found an inverse relationship between male pattern baldness and prostate cancer.

In another study conducted in 2012, the relationship between male pattern baldness and prostate cancer was investigated.

In another study conducted in 2012, it was shown that vertex baldness at the age of 40 (forty) may be an increased risk factor for early-onset prostate cancer. A 2010 study showed that early-onset male pattern baldness may be an early indicator of benign prostatic hyperplasia.

In a study conducted in 2011, it was shown that prostate cancer patients in their 20s (twenties) have male pattern baldness twice as much as the normal population. Studies do not support each other and different results are obtained in each study. More studies are needed on the relationship between male pattern baldness and prostate cancer.